Philippines detects local transmission of Omicron BA.2.12.1 subvariant
MANILA, May 17 (Xinhua) -- The Philippines' Department of Health (DOH) confirmed on Tuesday local transmission of the highly transmissible Omicron BA.2.12.1 subvariant of COVID-19 in the Southeast Asian country.
Health Undersecretary Maria Rosario Vergeire said that local clusters of the BA.2.12.1 variant infection have been detected in Metro Manila, the Western Visayas region in the central Philippines, and Puerto Princesa city in Palawan province.
"It means that the cases we detected in these areas are not linked to imported cases," Vergeire told a virtual media briefing.
The Philippines has detected 17 BA.2.12.1 cases so far.
"Now that we have local transmission of Omicron BA.2.12.1, we must act fast," Vergeire said, urging local government units to "actively look for cases and immediately isolate" suspected cases.
She said there is no community transmission yet in the country.
Studies have showed that BA.2.12.1 is highly transmissible due to additional mutations than the original Omicron strain. While this sublineage has not been observed to lead to more severe disease or fatality, it has the potential for immune escape.
The Philippines has so far reported 3,688,292 confirmed cases of COVID-19, including 60,458 deaths. The number of new COVID-19 cases continues to decline, averaging 157 cases a day.
Photos
- China’s central bank to issue commemorative coins on cultural theme of auspiciousness, including two heart-shaped coins
- Population of endangered black-headed gulls exceeds 10,000 mark in NE China’s coastal city of Panjin
- China's self-developed floating airship breaks record
- Chinese germplasm bank conserves biodiversity in warm temperate zone
Related Stories
- World’s 1st Omicron-specific inactivated vaccine administered in China’s Hangzhou
- New Zealand reports first Omicron BA.4 variant
- Dynamic zero-COVID approach best option for China in fighting Omicron
- U.S. economy shrinks in Q1 amid Omicron surge, high inflation, raising recession fear
- China's Omicron vaccine expected to complete clinical trials in 3-4 months
Copyright © 2022 People's Daily Online. All Rights Reserved.